In October, the I’M WOMAN Trial team exchanged knowledge in Tanzania on the benefits of tranexamic acid (TXA) for severe bleeding in women after childbirth, to prevent maternal deaths.
Practising clinicians in obstetrics and gynaecology, including doctors, nurses and midwives involved in recruiting women to the I’M WOMAN Trial, pledged to advocate for the use of TXA to treat postpartum haemorrhage (PPH). Read more below:
From top left to bottom right:
“I promise that I will educate others on the important use of tranexamic acid and importance of eligible women being randomised.” –Delila Msigwa, midwife, Tumbi Regional Referral Hospital
“I promise to advance research on TXA and obstetric haemorrhage in Tanzania and beyond.” –Professor Projestine Muganyizi, National Coordinator
“I promise to use TXA where indicated so that I can be an ambassador on the use of TXA to my colleagues.” –Dr Delfina Mkenda, Mbeya Zonal Referral Hospital
“I will disseminate knowledge on the importance of TXA in PPH management to other clinicians.” –Dr Jackson Malata, Mbeya Zonal Referral Hospital
“I promise to speak loudly about the advantages of TXA in preventing death from bleeding.” –Raison Kibona, midwife, Muhimbili National Hospital
“I promise to mentor my colleagues inside and outside my faculty to implement the use of TXA (within three hours of birth).” -Dr Deodata Ruganuza, Principal Investigator, Morogoro Regional Referral Hospital
“I will emphasise the importance of tranexamic acid to prevent PPH as it maintains the blood clot formed at the bleeding site. Administer tranexamic acid as soon as possible for a better result.” – Hawa Said, nurse and midwife, Morogoro Regional Referral Hospital
“I promise I am going to advise pregnant women who have potential risk to be involved in the trial.” –Dr Lawrence Kapinga, Mbeya Regional Referral Hospital
From left to right:
“I will use different forums like the Maternal and Perinatal Death Surveillance and Response meeting to increase awareness on the proper use of TXA” –Dr Enid Chiwanga, Principal Investigator, Dodoma Regional Referral Hospital
“I will recruit as many eligible women to prevent PPH” –Sister Mwamini Musa, midwife, Dodoma Regional Referral Hospital
“I will talk to my colleagues about the importance of using TXA early to a bleeding woman […]” –Dr Idrisa Husseim, Temeke Hospital
“I promise I am going to advise the majority of surgeons to use tranexamic acid as a pre-operative medication.” –Dr Julius Nyambarino MwananyamalaRegional Referral Hospital
“I promise to raise awareness on the importance of TXA, not only in pregnant women, but also in surgical patients.” –Beligna Kapinga, Temeke Regional Referral Hospital
“I’ll go to an antenatal care clinic and raise awareness about the trial […] to capture more eligible women.” –Dr Alfred Secha, Muhimbili National Hospital
“I promise to share the benefits of TXA to all community health workers in reducing postpartum bleeding when correctly administered.” –Dr Luzango Maembe, Principal Investigator, Mwananyamala Regional Referral Hospital
“I will advise on the use and benefit of TXA on people who are at risk of having heavier bleeding and the surgeon needs to use TXA for the prevention and treatment of bleeding.” –Dickson Mollel, nurse, Mount MeruRegional Referral Hospital
“I promise to encourage my fellows on the use of tranexamic acid early within three hours [of birth].” –Dr Sangalala Mtingele, Amana Regional Referral Hospital
Sign up for the WOMAN Trials newsletter for all the latest news and exclusive updates on the WOMAN Trials and to join our global movement working towards safe childbirth for women everywhere, regardless of income, location or background.